Pulmonary embolism epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 5: Line 5:


==Overview==
==Overview==
Each year in United States, there are between 300,000 and 600,000 cases of pulmonary embolism (PE). If un-treated almost 1/3 of patient die, usually from recurrent PE. However, with prompt diagnosis and treatment, the mortality rate is only ~ 2 – 8%. Unfortunately, 2/3 of all cases of PE are diagnosed only on autopsy [http://stopdvt.org/Documents/AMA%20Fact%20Sheet%20Current%20Research.pdf]. It is the major contributing factor or a cause of death in 16% of the hospitalized patients.
Each year in United States, there are between 300,000 and 600,000 cases of pulmonary embolism (PE). If un-treated almost 1/3 of patient die, usually from recurrent PE. However, with prompt diagnosis and treatment, the mortality rate is only ~ 2 – 8%. Unfortunately, 2/3 of all cases of PE are diagnosed only on autopsy. [http://stopdvt.org/Documents/AMA%20Fact%20Sheet%20Current%20Research.pdf] PE is the major contributing factor or a cause of death in 16% of the hospitalized patients.


==Epidemiology and Demographics==
==Epidemiology and Demographics==

Revision as of 21:36, 14 December 2011

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism epidemiology and demographics

CDC on Pulmonary embolism epidemiology and demographics

Pulmonary embolism epidemiology and demographics in the news

Blogs on Pulmonary embolism epidemiology and demographics

Directions to Hospitals Treating Pulmonary embolism epidemiology and demographics

Risk calculators and risk factors for Pulmonary embolism epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]

Overview

Each year in United States, there are between 300,000 and 600,000 cases of pulmonary embolism (PE). If un-treated almost 1/3 of patient die, usually from recurrent PE. However, with prompt diagnosis and treatment, the mortality rate is only ~ 2 – 8%. Unfortunately, 2/3 of all cases of PE are diagnosed only on autopsy. [3] PE is the major contributing factor or a cause of death in 16% of the hospitalized patients.

Epidemiology and Demographics

Horlander et al analyzed multiple-cause mortality files compiled by the National Center for Health Statistics from 1979 to 1998. They reported that out of 42932973 deaths that occurred, almost 600,000 patients (approximately 1.5 percent) had been diagnosed with PE, and it was the presumed cause of death in 200,00 patients.[1]

Only 10-20% of VTE is clinically recognized, as depicted by the figure below

References

  1. Horlander KT, Mannino DM, Leeper KV (2003). "Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data". Arch Intern Med. 163 (14): 1711–7. doi:10.1001/archinte.163.14.1711. PMID 12885687.

Template:WH Template:WS